Anti-tumor comprising boroproline compounds

Details for Australian Patent Application No. 2005211682 (hide)

Owner Point Therapeutics, Inc.

Inventors Wallner, Barbara P.; Miller, Glenn

Agent Freehills

Pub. Number AU-A-2005211682

Parent 781897

Filing date 23 September 2005

Wipo publication date 20 October 2005

International Classifications

A61K 031/69 - Boron compounds

A61P 035/00 Antineoplastic agents

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

Event Publications

13 October 2005 Complete Application Filed

20 October 2005 Application Open to Public Inspection

  Published as AU-A-2005211682

24 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005211683-An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method

2005211681-Method and apparatus for controlling airflow